C-Jun N-terminal kinase activation contributes to reduced connexin43 and development of atrial arrhythmias

Cardiovascular Research

Volumn 97, Issue 3, 2013, Pages 589-597

  Yan, Jiajie ^a,b,c   Kong, Wei ^b,c   Zhang, Qiang ^a,b,d   Beyer, Eric C ^e   Walcott, Gregory ^a,b   Fast, Vladimir G ^b,c   Ai, Xun ^a,b,c,f  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c and Radiation Oncology   (United States)

^d SUZHOU MUNICIPAL HOSPITAL   (China)

^e UNIVERSITY OF CHICAGO   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Atrial fibrillation; Cell cell communication; Gap junction; JNK

Indexed keywords

ANISOMYCIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CONNEXIN 43; SODIUM CHANNEL NAV1.5; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; GAP JUNCTION; HEART ATRIUM ARRHYTHMIA; HEART CONDUCTION; HEART LEFT ATRIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; WILD TYPE;

AGING; ANIMALS; ANISOMYCIN; ANTHRACENES; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; CELL COMMUNICATION; CELLS, CULTURED; CONNEXIN 43; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HEART ATRIA; HEART CONDUCTION SYSTEM; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; RABBITS;

EID: 84874263544     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs366     Document Type: Article

References (30)

1. Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010;90:1507-1546.
2. Petrich BG, Eloff BC, Lerner DL, Kovacs A, Saffitz JE, Rosenbaum DS et al. Targeted activation of c-jun n-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. J Biol Chem 2004;279:15330-15338.
3. Karin M. Inflammation-activated protein kinases as targets for drug development. Proc Am Thorac Soc 2005;2:386-390; discussion 394-385.
4. Rich MW. Epidemiology of atrial fibrillation. J Interv Card Electrophysiol 2009;25:3-8.
5. Saffitz JE, Davis LM, Darrow BJ, Kanter HL, Laing JG, Beyer EC. The molecular basis of anisotropy: role of gap junctions. J Cardiovasc Electrophysiol 1995;6:498-510.
6. Kanagaratnam P, Rothery S, Patel P, Severs NJ, Peters NS. Relative expression of immunolocalized connexins 40 and 43 correlates with human atrial conduction properties. J Am Coll Cardiol 2002;39:116-123.
7. Duffy HS, Wit AL. Is there a role for remodeled connexins in AF? No simple answers. J Mol Cell Cardiol 2008;44:4-13.
8. Garner AP, Weston CR, Todd DE, Balmanno K, Cook SJ. Delta mekk3:Er* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the g2 checkpoint. Oncogene 2002;21:8089-8104.
9. Hazzalin CA, Le Panse R, Cano E, Mahadevan LC. Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction. Mol Cell Biol 1998;18:1844-1854.
10. Petrich BG, Gong X, Lerner DL, Wang X, Brown JH, Saffitz JE et al. C-jun n-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. Circ Res 2002;91:640-647.
11. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu Wet al. Sp600125, an anthrapyrazolone inhibitor of jun n-terminal kinase. Proc Natl Acad Sci USA 2001;98: 13681-13686.
12. Ai X, Pogwizd SM. Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2a. Circ Res 2005;96:54-63.
13. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 2007;100:1512-1521.
14. Fast VG, Sharifov OF, Cheek ER, Newton JC, Ideker RE. Intramural virtual electrodes during defibrillation shocks in left ventricular wall assessed by optical mapping of membrane potential. Circulation 2002;106:1007-1014.
15. Eloff BC, Lerner DL, Yamada KA, Schuessler RB, Saffitz JE, Rosenbaum DS. High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc Res 2001;51:681-690.
16. Lammers WJ, Schalij MJ, Kirchhof CJ, Allessie MA. Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol 1990;259:H1254-1263.
17. Ai X, Zhao W, Pogwizd SM. Connexin43 knockdown or overexpression modulates cell coupling in control and failing rabbit left ventricular myocytes. Cardiovasc Res 2010;85:751-762.
18. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 2011;58:2225-2232.
19. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study. JAMA 1994;271:840-844.
20. Verheule S, van Kempen MJ, te Welscher PH, Kwak BR, Jongsma HJ. Characterization of gap junction channels in adult rabbit atrial and ventricular myocardium. Circ Res 1997;80:673-681.
21. Tuomi JM, Tyml K, Jones DL. Atrial tachycardia/fibrillation in the connexin 43 g60s mutant (oculodentodigital dysplasia) mouse. Am J Physiol Heart Circ Physiol 2011;300:H1402-11.
22. Beauchamp P, Yamada KA, Baertschi AJ, Green K, Kanter EM, Saffitz JE et al. Relative contributions of connexins 40 and 43 to atrial impulse propagation in synthetic strands of neonatal and fetal murine cardiomyocytes. Circ Res 2006;99: 1216-1224.
23. Bikou O, Thomas D, Trappe K, Lugenbiel P, Kelemen K, Koch M et al. Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model. Cardiovasc Res 2011;92:218-225.
24. Teunissen BE, Jansen AT, van Amersfoorth SC, O'Brien TX, Jongsma HJ, Bierhuizen MF. Analysis of the rat connexin 43 proximal promoter in neonatal cardiomyocytes. Gene 2003;322:123-136.
25. Bourgeois EB, Bachtel AD, Huang J, Walcott GP, Rogers JM. Simultaneous optical mapping of transmembrane potential and wall motion in isolated, perfused whole hearts. J Biomed Opt 2011;16:096020.
26. Baba S, Dun W, Hirose M, Boyden PA. Sodium current function in adult and aged canine atrial cells. Am J Physiol Heart Circ Physiol 2006;291:H756-H761.
27. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res 1986; 58:356-371.
28. Orlandi A, Francesconi A, Marcellini M, Ferlosio A, Spagnoli LG. Role of ageing and coronary atherosclerosis in the development of cardiac fibrosis in the rabbit. Cardiovasc Res 2004;64:544-552.
29. Anyukhovsky EP, Sosunov EA, Plotnikov A, Gainullin RZ, Jhang JS, Marboe CC et al. Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis. Cardiovasc Res 2002;54:462-469.
30. Huang C, Ding W, Li L, Zhao D. Differences in the aging-associated trends of the monophasic action potential duration and effective refractory period of the right and left atria of the rat. Circ J 2006;70:352-357.